Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Topical INCB-018424 displays safety and efficacy in patients with psoriasis

March 13, 2009

AndroScience announces phase IIa study results for ASC-J9 in acne

March 10, 2009

Phase II psoriasis study of Arana's ART-621 successfully completed

March 9, 2009

Anacor reports encouraging results from phase I AN-2898 safety trial

March 9, 2009

Peplin reports phase IIb actinic keratosis trial results for PEP-005

March 9, 2009

Serentis initiates phase II trial of SRD-174 for pruritus in atopic dermatitis patients

March 5, 2009

New peptides claimed by Les Biotechnologies Oceanova for dermatological disorders

March 4, 2009

RegeneRx provides update on phase II RGN-137 trial in venous stasis

March 2, 2009

Phase III Cyzact results fail to meet primary endpoint

Feb. 24, 2009

FDA issues public health advisory for Raptiva, EMEA recommends suspension

Feb. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.